All posts by imreal

Business: Insurance

The Impact of the Community Rating System

Leave a comment


News Image


MILWAUKEE (PRWEB)

Hurricanes Sandy and Katrina reeked havoc on our southern and eastern coastlines. With recent flooding along the Mississippi River and the near-miss of Hurricane Barry on the Gulf Coast is a reminder of the constant flood risk faced by communities and the need to be prepared for flood events.

In a new article released in the Applied Economic Perspectives & Policy, “Flood Insurance and Claims: The Impact of the Community Rating System,” Eugene Frimpong from East Carolina University and Ardian Harri, Daniel Petrolia, and John Cartwright from Mississippi State University look into what it would take to increase participation in the National Flood Insurance Program (NFIP).

Petrolia says, “We find a positive relationship between participation in the Community Rating System (CRS) and participation in the NFIP. However, we find that only those communities participating at the highest levels of the CRS realize real reductions in flood claims. So the policy discounts associated with CRS participation appear to be attracting more homeowners to insure, but only in very limited cases do the levels (and types) of CRS participation appear to lead to real reductions in exposure.

If you are interested in setting up an interview with Petrolia, please contact Allison Scheetz in the AAEA Business Office.

About AAEA: Established in 1910, the Agricultural & Applied Economics Association (AAEA) is the leading professional association for agricultural and applied economists, with 2,500 members in more than 60 countries. Members of the AAEA work in academic or government institutions as well as in industry and not-for-profit organizations, and engage in a variety of research, teaching, and outreach activities in the areas of agriculture, the environment, food, health, and international development. The AAEA publishes two journals, the American Journal of Agricultural Economics and Applied Economic Perspectives & Policy, as well as the online magazine Choices and the online open access publication series Applied Economics Teaching Resources. To learn more, visit http://www.aaea.org.

Share article on social media or email:

Business: Executives

C.A. Short Company Expands Executive Team, Appoints Christopher Cheney Chief Operating Officer

Leave a comment


https://www.prweb.com/

Christopher Cheney


CHARLOTTE, N.C. (PRWEB)

C.A. Short Company, a leading provider of recognition and engagement solutions, today announced the appointment of Christopher Cheney to the role of Chief Operating Officer. With extensive management experience, Cheney brings valuable leadership to C.A. Short’s executive team during a period of rapid growth. As COO, Cheney will lead operations and direct the company’s customer experience, merchandising and sourcing, implementation, technology and logistical/fulfillment functions.

Jeff Ross, CEO & CFO of C.A. Short had this to say regarding Cheney’s addition, “We are very fortunate to have someone of Christopher’s caliber, experience and proven track record of execution to join our team. We are at a major point in our growth and Christopher’s leadership will be an integral part in successfully implementing our strategy and taking advantage of the market opportunities ahead. We could not be more excited here at C.A. Short Company. Let’s go!!”

Prior to joining C.A. Short, Cheney acted as Senior Vice-President of Operations for Inspirus, a Sodexo Company, in southeast Texas. There he put his expertise to work optimizing company processes and boosting product capacities. Cheney has more than twenty-five years of experience in the recognition industry and will bring a wealth of knowledge to C.A. Short Company.

Cheney is a graduate of the University of Massachusetts Dartmouth. He is a Six Sigma Green Belt with additional certifications in Lean and DFSS.

About C.A. Short Company

C.A. Short offers industry leading recognition, engagement and incentive solutions through innovative design, rapid implementation, and “all-in” exceptional service, delivering positive behavior changes and measurable, impactful business results.

http://www.cashort.com

Share article on social media or email:

Health

We Will Fight Purdue Settlement on Behalf of Opioid-Dependent Babies

Leave a comment


“This fight is not over, nor should it be.” – Celeste Brustowicz


NEW ORLEANS (PRWEB)

Attorneys, medical experts and non-profit leaders represented by the Opioid Justice Team and more than 35 class actions representing infants born already opioid-dependent due to the mother’s use of prescription opioids while pregnant, intend to fight vigorously Purdue Pharma’s efforts to shield itself from thousands of lawsuits filed in relation to America’s prescription opioid crisis, fueled in large part by the marketing of Purdue’s OxyContin drug.

“Our clients, the innocent victims of this nation’s unbridled corporate promotion of an addictive substance to thousands of men and women, but especially child-bearing aged women, will not accept the bankruptcy settlement,” said Lead Attorney Celeste Brustowicz. “This proposal ignores the most critical victims of this crisis, who will suffer birth defects like Spina Bifuda and Gillam-Barre, and very often be sent home from hospitals as opioid-free babies with unsuspecting parents who may not see developmental disabilities in these children for months.”

According to a settlement announced Sunday, Purdue hopes Chapter 11 bankruptcy will prompt an automatic stay of current civil litigation against the company over the opioid epidemic. Though Purdue estimates the value of the settlement at $10 billion, others with a vested interest in the proposal believe this is too optimistic a calculation and could be worth only half that much. Others oppose the deal because the restructured company proposed in the settlement allows on-going sales of OxyContin to fund the settlement structure, rather than the existing profits of Purdue’s owners themselves.

“After two decades of indiscriminate destruction and devastation to families nationwide, it is insincere for Purdue to declare in the days preceding its bell-weather trial in Cleveland, that it and the Sackler family alike are in a rush to get money to the politicians, whether it be the states, counties or cities,” said Ms. Brustowicz. “Purdue voluntarily surrendering itself by agreeing to enjoin themselves from engaging in misconduct is unprecedented, even by Purdue’s own lawyers.”

Currently, cases against Purdue because of the prescription opioid crisis linked to drug manufacturer and distributor falsehoods and suspect marketing practices, number in the millions of individuals. Among these are at least 250,000 infants represented by the Opioid Justice Team. These attorneys and medical experts fighting on behalf of opioid-dependent infants estimate a baby with Neo-Natal Abstinence Syndrome (NAS) is born in the U.S. every 15 minutes.

“This is an insensitive response to children and their guardians. The time for defendants and Big Pharma to make amends with babies suffering from Neo-natal Abstinence Syndrome and related maladies is long overdue,” said Ms. Brustowicz. “This fight is not over, nor should it be.”

Ms. Brustowicz said her team will continue to push for a legal track in the Multi-District Litigation before Judge Polster, whom drug manufacturer representatives moved to have removed from the case over the weekend, as well as in the 35 individual states which have filed NAS class actions.

“We’re on the side of the angels and we will continue to press on,” she said.

Share article on social media or email:

Industry: Healthcare

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Leave a comment


Drs. Shipra Gandhi and Pawel Kalinski will lead a Department of Defense-funded clinical trial assessing a three-pronged immunotherapy strategy for metastatic breast cancer.

Drs. Shipra Gandhi and Pawel Kalinski will lead a Department of Defense-funded clinical trial assessing a three-pronged immunotherapy strategy for metastatic breast cancer.

Our strategy uses a unique combination of biologic agents to make tumors visible to the immune system by making them look like tissue that’s been infected by a virus. Findings from earlier studies lend strong support for assessing this combination even in aggressive and hard-to-treat cancer types.


BUFFALO, N.Y. (PRWEB)

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense (DoD) grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center. The four-year, $6.42 million Breakthrough Award (award no. W81XWH-19-1-0674/BC180510) through the DoD’s Breast Cancer Research Program will fund a clinical trial in patients with brain-metastatic breast cancer, to be led by Shipra Gandhi, MD, Assistant Professor of Oncology in the Department of Medicine at Roswell Park.

The phase II trial, slated to open in 2020, would be the first clinical study to assess the effectiveness of a three-pronged strategy combining distinct immunotherapy approaches:


  • A new dendritic-cell treatment vaccine developed by Dr. Kalinski and colleagues in collaboration with Brian Czerniecki, MD, PhD, Chair of the Breast Oncology Department at Moffitt Cancer Center in Tampa, Florida

  • Chemokine modulation using a combination proposed and validated by Dr. Kalinski as an optimized adjuvant for dendritic-cell vaccines, incorporating rintatolimod (brand name Ampligen) and interferon alfa-2b (brand name Intron A)

  • Immune checkpoint inhibition

Alone, these therapies are effective for a limited number of patients, but evidence suggests that together they may help break through a persistent challenge in oncology: how to turn “cold” tumors that don’t respond to existing therapies into “hot” ones that the immune system can be trained to recognize and pursue.

“A major limitation of cancer immunotherapy is that tumors adapt to naturally occurring effector cells by shutting down production of the relevant chemokines in the tumor microenvironment,” says Dr. Kalinski, the overall Principal Investigator for the project. “Our strategy uses a unique combination of biologic agents to make tumors visible to the immune system by making them look like tissue that’s been infected by a virus. We’ve never tested them all together before in patients, but the findings from earlier clinical and preclinical studies lend strong support for assessing this combination even in the most aggressive and hard-to-treat cancer types.”

Three key factors distinguish this platform for combination immunotherapy:

  • The approach is tumor-selective, meaning it can act preferentially to generate responses only in cancer tissues, but not in normal, noncancerous tissue

  • It selectively activates so-called “good” chemokines in the tumor microenvironment and promotes selective attraction of desirable tumor-fighting immune cells, but avoids activating “bad” chemokines that attract undesirable suppressive cells

  • These therapies have been shown in preclinical and clinical trials to be associated with low toxicity and few adverse side effects

The team will study this approach first in patients with localized brain-metastatic breast cancer (BMBC), or breast cancer that has begun to spread to the brain but is not yet widely disseminated. A companion clinical trial in patients with disseminated, leptomeningeal BMBC, to be led by Peter A. Forsyth, MD, Chair of the Neuro-Oncology Department at Moffitt Cancer Center, in collaboration with Dr. Czerniecki, partnering Principal Investigator on the project, will move forward with additional DoD funding of more than $8 million. Both trials will be available to patients at Roswell Park and at Moffitt.

“There are currently no curative treatments for breast cancer that has spread to and grown in the brain, and the options we have often involve significant side effects or harm to healthy tissues. So this is an area of pronounced clinical need,” notes Dr. Gandhi, Principal Investigator on the Roswell Park study. “We’re particularly encouraged to be developing a strategy that has the potential to be effective for patients with various breast cancer subtypes — cancers that are positive for HER2 markers as well as notoriously aggressive triple-negative breast cancers.”

Roswell Park has three other studies in progress assessing some of the component elements of this new therapeutic platform:

  • Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients with Colorectal Cancer Metastatic to the Liver (NCT03403634 – actively recruiting)

  • Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients with Prostate Cancer Before Surgery (NCT NCT03899987 – authorized by the FDA and Roswell Park’s Internal Review Board; not yet recruiting)

  • Chemokine Modulation Therapy and Pembrolizumab in Treating Participants with Metastatic Triple-Negative Breast Cancer (NCT NCT03599453 – actively recruiting)

AIM ImmunoTech Inc. has agreed to provide rintatolimod for the new DoD-funded studies in brain-metastatic breast cancer, as well as these ongoing studies.

Dr. Kalinski gratefully acknowledges earlier support for his work through donations to Roswell Park as a critical foundation that allowed him to pursue and attract outside funding for this work.

The new study in patients with BMBC is not yet open to accrual. For information about other clinical trials currently available at Roswell Park, please visit roswellpark.org/clinical-trials, call 1-800-ROSWELL (1-800-767-9355) or contact Roswell Park by email at askroswell@roswellpark.org.

This release is also available on the Roswell Park website: https://www.roswellpark.org/media/news/roswell-park-moving-unique-immunotherapy-platform-forward-642-million-dod-grant

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

Share article on social media or email:

Business: Insurance

Fargo named division manager for North American Title Co.’s Southern Nevada region

Leave a comment


https://www.prweb.com/

Jeff Fargo, Division Manager, North American Title Co.’s Southern Nevada region

I have long been devoted to helping my customers apply social media, video, data mining and migration patterns to create substantial growth for their businesses and combining these efforts with States Title’s vision for the future of our industry will be a game changer for my customers.


SAN FRANCISCO (PRWEB)

North American Title Co. (NATC) has named Jeff Fargo division manager for its Southern Nevada region. Fargo brings real estate and title insurance experience to his position.

“Jeff’s real estate knowledge and leadership ability makes him uniquely qualified to lead our associates in what promises to be a most rewarding and productive future in this dynamic region,” said Chad Nichols, NATC’s Western region president. “His focus on the customer experience combined with his passion for technology is an excellent complement to our united efforts to build the title company of the future.”

Born into a real estate development family in Upstate New York, Fargo spent much of his early career overseeing his family’s real estate portfolio until moving to St. George, Utah, in 2005. There, he joined Coldwell Banker Commercial KGA as an associate broker. For the past five years, he worked as a marketing executive for First American Title, where, in 2018, he was awarded the national DPK Circle of Excellence award for year-over-year revenue growth.

“As a student of emerging technology, I am beyond excited to join the amazing team that is defining the future for our industry through machine intelligence,” Fargo said. “I have long been devoted to helping my customers apply social media, video, data mining and migration patterns to create substantial growth for their businesses and combining these efforts with States Title’s vision for the future of our industry will be a game changer for my customers.”

NATC is part of the States Title family of companies, a top 10 title insurance and settlement provider. Based in San Francisco, States Title is intelligently transforming closings by applying machine intelligence to make real estate transactions simple and efficient, enhancing the customer experience and enabling loans to close faster and at a lower cost.

Fargo works out of NATC’s Las Vegas office at 8485 W. Sunset Road, Suite 111, Las Vegas, NV 8911392130, and can be reached at (877) 430-6282.

About North American Title

With close to 1,000 associates and a network of branches from coast to coast, North American Title Company (NATC) is among the largest real estate settlement service providers in the United States. Through its relationship with an expanding affiliate network, NATC provides or is able to coordinate real estate settlement services in all 50 states. With more than 100 offices across the country, NATC offers a depth and breadth of local expertise and knowledge in many of the premier real estate markets. NATC’s parent company is States Title Holding Inc., headquartered in San Francisco, California. Founded by Max Simkoff and backed by a significant financial investment from Lennar and leading venture capitalists in Silicon Valley, States Title uses machine intelligence to deliver a simple and efficient title and escrow solution. Learn more at http://www.nat.com.

Share article on social media or email:

Business: Executives

IWCO Direct’s Director of Postal Affairs Elected as New MTAC Industry Vice Chair

Leave a comment


Bob Rosser, IWCO Direct

IWCO Direct’s Bob Rosser has been elected Industry Vice Chair of MTAC.

Bob has dedicated his entire career to mail, and he will be a great champion for members of MTAC, its member associations, and mailing industry stakeholders as he focuses on helping to create a stronger Postal Service.” — Jim Andersen, executive chairman of IWCO Direct


CHANHASSEN, Minn. (PRWEB)

IWCO Direct, a leading provider of data-driven direct marketing solutions, announced Bob Rosser, its Director of Postal Affairs, has been appointed Industry Vice Chair of the Postmaster General’s Mailers’ Technical Advisory Committee (MTAC). Rosser was elected to the position at a recent MTAC meeting and will serve in the role through the end of 2020, when he will become MTAC Industry Chair through the end of 2023.

MTAC is a venue for the United States Postal Service (USPS) to share technical information with mailers, and to receive their advice and recommendations on matters concerning mail-related products and services. MTAC works for the mutual benefit of mailing industry stakeholders and the Postal Service to enhance customer value and expand the use of these products and services. In his new role with MTAC, Rosser aims to focus on keeping the mail channel affordable and providing consistent and predictable mail delivery service. He brings 38 years of experience to his role, during which he has worked with all classes of mailers, and all departments of the USPS, Postal Regulatory Commission, USPS Office of Inspector General, and many trade associations.

Rosser has been with IWCO Direct since 2004, adding to the company’s extensive postal expertise. In addition to its work with MTAC, the company is also involved with APTech, EMA, and PostCom. IWCO Direct works closely with its clients to develop postal strategies that make the most effective use of their mailing budgets and provide more precise in-home delivery dates. The company pioneered the practice of integrated commingling in 1995 and has continued to innovate with optimization techniques like density-driven regional commingling and preparing mail for walk-sequence carrier route discounts.

“IWCO Direct believes it’s important to be an advocate for the mailing industry and to help ensure the Postal Service’s long-term health by helping it adapt to change,” said Jim Andersen, executive chairman of IWCO Direct. “Bob has dedicated his entire career to mail, and he will be a great champion for members of MTAC, its member associations, and mailing industry stakeholders as he focuses on helping to create a stronger Postal Service.”

About IWCO Direct

As a leading provider of data-driven direct marketing solutions, IWCO Direct’s Power your Marketing™ approach drives response across all marketing channels to create new and more loyal customers. The company’s full range of services includes strategy, creative, and execution for omnichannel marketing campaigns, along with one of the industry’s most sophisticated postal logistics strategies for direct mail. Through Mail-Gard®, IWCO Direct offers business continuity and disaster recovery services to protect against unexpected business interruptions, along with providing print and mail outsourcing services. The company is ISO/IEC 27001 Information Security Management System (ISMS) certified through BSI, reflecting its commitment to data security. Stay current on direct marketing trends, industry news, postal regulations, and more by subscribing to IWCO Direct’s SpeakingDIRECT blog.

IWCO Direct is a wholly owned subsidiary of Steel Connect, Inc., a publicly traded diversified holding company (Nasdaq Global Select Market symbol “STCN”); Steel Connect, Inc. has two wholly owned subsidiaries, IWCO Direct and ModusLink Corporation. For more information, please visit About Steel Connect, Inc.

Share article on social media or email:

Health

The New England Center for Children Announces Partnership with New School In Lebanon for Children with Autism

Leave a comment


https://www.prweb.com/

One Two Three Autism School, Beirut, Lebanon

“One Two Three Autism School’s partnership with NECC enables their staff and NECC-trained Lebanese teachers to provide the highest quality ABA therapy to Lebanese children,” said Saritta Trad, a co-founder and mother whose son attends the school.


SOUTHBOROUGH, Mass. (PRWEB)

The New England Center for Children® (NECC®), a global leader in autism education and research, announced today a partnership with One Two Three Autism School in Beirut, Lebanon, to serve children with autism and their families. NECC was contracted to manage school operations, teaching, applied behavior analysis (ABA) consulting, and professional development. One Two Three is the first and only school in Lebanon for children with autism.

“Autism treatment in much of the Middle East remains scarce, leaving thousands of children and families lacking resources,” said Vincent Strully, President and CEO of The New England Center for Children. “NECC is excited to bring proven, research-based ABA teaching practices to Lebanon through our management of One Two Three Autism School. Our growing international programs and services have reached 18 countries, bringing effective, evidence-based educational services to underserved children with autism and their families.”

“Autism services are sorely needed in Lebanon, as I experienced with my own son. The autism rate for children in Beirut and Mount Lebanon is one in 67,” said Saritta Trad, a co-founder and mother whose son attends the school. “For One Two Three Autism School, we turned to the world leaders in autism education. Our partnership with NECC enables their staff and NECC-trained Lebanese teachers to provide the highest quality ABA therapy, occupational therapy, and speech and language therapy to Lebanese children.”

“NECC is excited to be part of One Two Three Autism School and we look forward to helping transform the lives of children with autism and their families,” said Kristin Buchanan, NECC’s Global Consulting Director. “By empowering teachers worldwide with the knowledge and tools of ABA, together we can create more success stories like One Two Three.”

NECC Bringing Autism Education to Underserved Nations

NECC has helped thousands of children in the Middle East and worldwide through its centers, consulting services, and ACE® ABA Software System. In addition to Lebanon, NECC operates or consults in Kuwait City, Kuwait; Dubai and Abu Dhabi in the UAE; Doha, Qatar; Gurgaon, India; Riyadh and Dammam in Saudi Arabia; and in Brazil, Australia, Italy, England, Canada and other countries. The ACE Software is currently used in 13 countries. NECC employs close to 300 people internationally, a quarter of whom are U.S. citizens and the remaining are nationals. NECC employs more than 50 percent of the BCBAs in the entire Gulf Region.

An important part of NECC programs is the integration of local language and cultural and religious practices into the curriculum. Key to NECC’s mission is training and educating local staff to ensure knowledge transfer, program sustainability, and local growth of ABA programs. More schools and centers have followed suit in applying ABA practices, looking to achieve the results of NECC.

International Influence and Reach

Reflecting its worldwide reputation, NECC received the 2017 Award for International Dissemination of Behavior Analysis from the Society for the Advancement of Behavior Analysis (SABA), the peer academic organization of applied behavior analysis. The highly respected award is given to a person or organization demonstrating a significant and sustained contribution to the dissemination and development of ABA outside of the United States.

NECC’s professional development program has graduated many of the autism service industry’s leaders – teachers, behavior analysts, and researchers inside and outside of NECC whose training and dedication have helped thousands of children with autism and their families.

“The reach and influence of NECC are truly inspiring, and their impact in disseminating applied behavior analysis best practices,” said Dr. Maria Malott, CEO of the Association for Behavior Analysis International. “NECC has played a large part in making inroads for behavior analysis in the Middle East and worldwide.”

About One Two Three Autism School

The establishment of One Two Three Autism School was inspired by Bachir Sarkis and Saritta Trad, who were not able to find the appropriate education provider for their child in Lebanon. They wanted to build a school that could help provide quality services for their child as well as children in the community. Bachir’s uncle, Sarkis Sarkis, helped to fund the school and NECC services through a generous donation. One Two Three Autism School’s geographical location provides easy travel for families from other countries in the region. One Two Three Autism School hopes to provide an educational setting for Lebanese and other Middle Eastern citizens who are struggling to find an appropriate school for their children.

About The New England Center for Children

The New England Center for Children® (NECC®) is an award-winning autism education center and research institute. Our community of teachers, researchers, and clinicians have transformed the lives of thousands of children with autism worldwide through education, research, and technology. The Center provides comprehensive services to maximize independence: home-based, day, and residential programs, partner classrooms in public school systems, consulting services, the ACE® ABA Software System (http://www.acenecc.org), teacher professional development, and research on educational best practices.

NECC is committed to staff professional development, partnering with local colleges to provide on-site graduate training and degrees at little to no cost to the NECC teacher. The result is a growing pool of exceptional teachers trained in best-in-class methodologies, whether they continue their careers at NECC or move on to public schools or private agencies. The New England Center for Children is based in Southborough, MA, and operates a center in Abu Dhabi, UAE. Learn more at http://www.necc.org.

Industry: Healthcare

eClinical Solutions’ Dawn Kaminski Serves as Co-Chair again for SCDM 2019

Leave a comment


elluminate Data Central is reducing the time spent on data review and reconciliation activities by 30%, said Diane Lacroix, Director of Data Management at eClinical Solutions.


BOSTON (PRWEB)

As leaders in the clinical data management industry, eClinical Solutions team members were selected to participate in SCDM 2019 as the co-chair, session leaders and expert speakers. Hosted annually by the Society of Clinical Data Management, SCDM is the world’s premier data management conference and brings together 70 speakers to discuss data management advances and technologies that are driving clinical trials and regulatory standards. The 2019 SCDM Annual Meeting will take place in Baltimore, Maryland from September 29 to October 2.

“Data management is core to our business, which is why SCDM is so important to us,” says Katrina Rice, eClinical Solutions’ Executive Vice President of Professional Services. “It is essential to give the life sciences industry the right tools for accurate and timely data review and management. We are extremely proud to be involved in this world-class event.”

The eClinical Solutions team will be participating in a variety of thought leadership sessions, as well as a product showcase.

Clinical Data Management 2022, with Dawn Kaminski, Amy Nordo (Pfizer), Drew Garty (Veeva Systems) and session chair Dan Crawford (Veeva Systems), will explore areas where technology will have the greatest impact: data workbenches, integration of EDC and risk based monitoring, and eSource. Artificial Intelligence to Solve Clinical’s “Big Data” Challenges will bring together leaders in clinical data technology innovation, including eClinical Solutions’s CTO, Sam Anwar, eClinical Solutions’s CEO, Raj Indupuri, Catherine Celingant (Pfizer) and Jason Raines (Apellis) for a discussion on opportunities for data management transformation leveraging AI and machine learning. Diane Lacroix will chair a session on An Agile Approach to Data Management: Improving the End-to-End Clinical Data Strategy and will be joined by Julie Savoia, eClinical’s Manager of Data Management & Training, Professional Services, as well as Cecilia Calcagno (PRA Health Sciences) and Elizabeth Thompson (Sarepta Therapeutics). Finally, eClinical Solutions’s CEO, Raj Indupuri, and Chief Marketing Officer, Sheila Rocchio, will speak on how digital data strategies are being designed and implemented across R&D organizations during Roadmap to D-Clinical along with Deborah Lucas (Ra Pharmaceuticals) and Chris Jennings (Triverus Consulting). More information can be found on the SCDM conference website.

The product showcase will focus on the elluminate®️ platform and elluminate Data Central which is enabling next generation data review and management. Data managers use elluminate Data Central to view and manage all their clinical data from numerous sources and to automate formerly manual data review processes. The product showcase will highlight how elluminate Data Central is being used by data managers and medical monitors for incremental data review, query, issue and workflow management and for comprehensive data and medical review using interactive visual patient profiles.

“elluminate Data Central is reducing the time spent on data review and reconciliation activities by 30%,” said Diane Lacroix, Director of Data Management at eClinical Solutions. “We are excited about showcasing these new capabilities and providing use cases and examples to data managers about how this product can help increase productivity and improve overall data quality.”

Details:

Session 1 – Clinical Data Management 2022: A Glimpse Into the Future with Dawn Kaminski | Monday, September 30, 2019, 11:15 AM-12:15 PM

Session 9 – Roadmap to D-Clinical – Designing Your Digital Data Strategy with Raj Indupuri and Sheila Rocchio | Monday, September 30, 2019: 4:00 PM-5:30 PM

Session 6 – Artificial Intelligence to Solve Clinical’s “Big Data” Challenges with Raj Indupuri and Sam Anwar | Tuesday, October 1, 2019, 1:30 PM-3:00 PM

Session 17 – An Agile Approach to Data Management: Improving the End-to-End Clinical Data Strategy with Diane Lacroix and Julie Savoia | Tuesday, October 1, 11:30 AM – 12:30 PM

elluminate®️ Product Showcase | Tuesday, October 1, 9:30 AM-10:15 PM

About eClinical Solutions

eClinical Solutions is a leading provider of cloud based enterprise software and software-driven clinical data services. The elluminate® platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies on more than 500 trials. For more information, visit http://www.eclinicalsol.com.

Share article on social media or email:

Business: Insurance

New PrismHR Initiatives Help HROs Boost Market Penetration, Gain Greater Value from the PrismHR Relationship

Leave a comment


“PrismHR Marketplace Access will take the marketing burden off the HRO so they can focus on their core business, while PrismHR Insurance Alliance ROI Calculator allows them to see tangible evidence of the true value of our leading Insurance Alliance products,” Gary Noke, President and CEO, PrismHR


AUSTIN, Texas (PRWEB)

Today at NAPEO’s 2019 Annual Conference & Marketplace, PrismHR, the leading HR technology software powering payroll, benefits and HR for small and medium-sized businesses across the U.S., announced key initiatives designed to increase revenue, achieve significant cost savings, and greatly improve client retention for its HR service providers in the company’s HRO partner network.

The two programs announced today include:


  • PrismHR Marketplace Access, a cooperative marketing program designed to increase client and worksite employee adoption of PrismHR Marketplace solutions by HROs’ small business customers and employees.

  • PrismHR Insurance Alliance ROI Calculator, a new online tool that illustrates the significant cost savings and increased revenue that HROs can achieve with Insurance Alliance partner products.

“Our HRO partners are looking for new ways to demonstrate value and to let their clients know about products that will make a real difference to them and their worksite employees,” said Gary Noke, President and CEO of PrismHR. “PrismHR Marketplace Access will take the marketing burden off the HRO so they can focus on their core business, while PrismHR Insurance Alliance ROI Calculator allows them to see tangible evidence of the true value of our leading Insurance Alliance products.”

PrismHR Marketplace

PrismHR Marketplace provides access to pre-integrated, validated connections from leading HR application providers. The Marketplace includes a wide range of solutions and service offerings ideal for small businesses and their employees.

PrismHR Marketplace Access

With PrismHR Marketplace Access, HROs can work directly with PrismHR to create direct marketing programs to their clients and worksite employees to improve awareness of PrismHR Marketplace solutions, increasing revenue and client retention. Participating Marketplace partners in the Marketplace Access Program can be found here.

PrismHR Insurance Alliance

The PrismHR Insurance Alliance enables PrismHR’s service provider customers to offer a range of A-rated, competitively priced ancillary insurance products to their clients, including voluntary life insurance, group accident insurance, dental, vision and more. In addition, enrollment in Insurance Alliance products is streamlined, and administration and reconciliation are also simplified. For more information, email insurance@prismhr.com.

About PrismHR

PrismHR’s mission is to fuel the growth of small and medium-sized businesses (SMBs) across the U.S. Our software, combined with our ecosystem of HR service providers, enables SMBs to manage payroll, benefits, and HR, leveling the playing field with large enterprises. Today, PrismHR software delivers world-class HR services to more than 88,000 organizations and over 2 million worksite employees, processing greater than $57 billion in payroll each year. PrismHR is located in Hopkinton, Mass. For more information, visit http://www.prismhr.com.

Share article on social media or email:

Business: Executives

Fairway America, LLC Welcomes New COO

Leave a comment


Anindya Roychowdhury

Anindya Roychowdhury

My endeavor would be to help the company realize its vision of becoming the go-to capital provider in the alternative real estate space by building an awareness of its offering among global investors looking for reliability and quality. – Anindya Roychowdhury


PORTLAND, Ore. (PRWEB)

Fairway America is proud to announce and welcome Anindya Roychowdhury as the company’s Chief Operating Officer. He will start in his new role on October 21, 2019, in Fairway America’s Portland, Oregon office.

Anindya joins the Fairway America team after over 17 years at KPMG in their India and Middle East offices, and he has a total of 25+ years’ experience negotiating, capital raising and bringing global and local companies together. Much of his career has been spent in leadership roles starting up profit centers and building cross-functional teams while growing them into market leaders in different geographies.

His key achievements and roles include: founding and growing KPMG’s Deal Advisory service line in Kuwait; establishing the Media & Entertainment vertical (now a major revenue line) in KPMG’s India practice; setting up the Project Advisory Division at Larsen & Toubro’s financial services subsidiary, L&T Finance (one of India’s largest conglomerates with revenues of $17 billion); and working as COO of KPMG Deal Advisory’s Saudi, Kuwait and Jordan cluster, functionally reporting to the Global COO. Anindya has also worked as a Vice President at AIA Capital, the Hong Kong-based investment banking subsidiary of AIG Inc., and as a Manager in India’s premier development bank, IDBI.

Anindya’s extensive experience includes international capital raising for mega projects, cross-border due diligence, valuations, restructuring and conducting comprehensive feasibility studies in infrastructure, real estate and logistics in major emerging markets. He has advised international corporations on expansion and market-entry strategies and has worked extensively with government entities, regulators, international and multilateral lenders, private equity funds, attorneys and investment banks as well as trade platforms, chambers of commerce and government embassies.

As an industry thought leader, Anindya has been interviewed and featured in publications and broadcasts with TIME, CNN, CNBC, BBC Financial Times, New York Times and International Herald Tribune. He holds a CGMA degree from CIMA (UK) and AICPA (USA), a CMA degree from CIMA (UK), an ACA degree from the Institute of Chartered Accountants of England & Wales and a bachelor’s degree with a major in economics from the prestigious Presidency College, Calcutta University in India.

“I’m ecstatic to have someone of Anindya’s caliber joining our firm. His credentials are impeccable, and his network is expansive. As we continue to expand our real estate private equity business, the addition of Anindya will help fuel the pace at which we are able to grow.”

−Matt Burk, Fairway America CEO

In his new role, Anindya will focus on expanding Fairway’s global and domestic institutional investor and client base, creating and growing the company’s real estate investment banking practice, and negotiating high-level joint ventures and other strategic alliances. He will play a senior leadership role in setting and executing strategy, particularly around capitalization of Fairway’s funds, syndications and managed accounts.

“I am thrilled to join Fairway’s dynamic team and become part of its exciting growth story. My endeavor would be to help the company realize its vision of becoming the go-to capital provider in the alternative real estate space by building an awareness of its offering among global investors looking for reliability and quality.”

−Anindya Roychowdhury

Share article on social media or email: